This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: China cellphone makers take SEP disputes home as global row escalates

By MLex Staff ( April 20, 2022, 08:03 GMT | Comment) -- Chinese cellphone makers have opened a new front in their battle with international owners of patents essential to implement the industry's standards. Yet again, they have turned to antitrust officials in China, after years of courtroom tussles proved to be costly, time-consuming and sometimes futile. Having said that, even a regulatory intervention could be an uphill battle, not only because some of the subjects appear to be out of reach, but also due to the need to follow Beijing's demands for stronger IP protection.Chinese cellphone manufacturers have opened a new front in their battle with international owners of patents essential to implement the industry's standards. Yet again, they have turned to antitrust officials in China, after years of courtroom tussles proved to be costly, time-consuming and sometimes futile....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections